1. Home
  2. SPOK vs MRVI Comparison

SPOK vs MRVI Comparison

Compare SPOK & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPOK
  • MRVI
  • Stock Information
  • Founded
  • SPOK 2004
  • MRVI 2014
  • Country
  • SPOK United States
  • MRVI United States
  • Employees
  • SPOK N/A
  • MRVI 560
  • Industry
  • SPOK Telecommunications Equipment
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPOK Telecommunications
  • MRVI Health Care
  • Exchange
  • SPOK Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • SPOK 379.1M
  • MRVI 350.1M
  • IPO Year
  • SPOK 1992
  • MRVI 2020
  • Fundamental
  • Price
  • SPOK $18.04
  • MRVI $2.42
  • Analyst Decision
  • SPOK Hold
  • MRVI Hold
  • Analyst Count
  • SPOK 1
  • MRVI 10
  • Target Price
  • SPOK $15.00
  • MRVI $5.84
  • AVG Volume (30 Days)
  • SPOK 170.2K
  • MRVI 1.5M
  • Earning Date
  • SPOK 10-29-2025
  • MRVI 08-11-2025
  • Dividend Yield
  • SPOK 6.88%
  • MRVI N/A
  • EPS Growth
  • SPOK 10.71
  • MRVI N/A
  • EPS
  • SPOK 0.83
  • MRVI N/A
  • Revenue
  • SPOK $140,742,000.00
  • MRVI $219,830,000.00
  • Revenue This Year
  • SPOK $2.26
  • MRVI N/A
  • Revenue Next Year
  • SPOK $3.69
  • MRVI $7.23
  • P/E Ratio
  • SPOK $21.87
  • MRVI N/A
  • Revenue Growth
  • SPOK 1.79
  • MRVI N/A
  • 52 Week Low
  • SPOK $13.55
  • MRVI $1.67
  • 52 Week High
  • SPOK $19.31
  • MRVI $9.60
  • Technical
  • Relative Strength Index (RSI)
  • SPOK 48.35
  • MRVI 49.60
  • Support Level
  • SPOK $17.61
  • MRVI $2.28
  • Resistance Level
  • SPOK $18.15
  • MRVI $2.47
  • Average True Range (ATR)
  • SPOK 0.33
  • MRVI 0.14
  • MACD
  • SPOK -0.08
  • MRVI -0.01
  • Stochastic Oscillator
  • SPOK 21.43
  • MRVI 27.45

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: